Akso Health Group
6 hedge funds and large institutions have $880K invested in Akso Health Group in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
73% more capital invested
Capital invested by funds: $510K → $880K (+$370K)
50% more funds holding
Funds holding: 4 → 6 (+2)
0.02% more ownership
Funds ownership: 0.04% → 0.05% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$521K |
| 2 |
Millennium Management
New York
|
+$127K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$5.93K |
| 4 |
PA
Pinnacle Associates
New York
|
+$5.53K |
| 5 |
Morgan Stanley
New York
|
+$2.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$184K |
| 2 |
VF
Virtu Financial
New York
|
-$131K |
AHG Hedge Fund Activity: Q1 2018 in Review
6 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q1 2018, worth a combined $880K — up 73% from $510K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AHG positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $521K. The largest seller was Citadel Advisors, exiting entirely with an estimated $184K sold.
- 6 institutional investors held Akso Health Group (AHG) as of Q1 2018, up from 4 in Q4 2017.
- Funds reported $880K of Akso Health Group stock for Q1 2018, up 73% quarter-over-quarter.
- 4 funds opened new Akso Health Group positions in Q1 2018 and 2 closed out, a net change of +2 holders.
- The largest Akso Health Group buyer in Q1 2018 was Acadian Asset Management, an estimated $521K added.
- The largest Akso Health Group seller in Q1 2018 was Citadel Advisors, an estimated $184K sold.
Based on aggregated 13F filings for Q1 2018.